دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Factors Predisposing to Survival After Resuscitation for Sudden Cardiac Arrest
Santo Ricceri, James W. Salazar, Andrew A. Vu, Eric Vittinghoff, ... Zian H. Tseng
doi : 10.1016/j.jacc.2021.03.299
Volume 77, Issue 19, 18 May 2021, Pages 2353-2362
In the POST SCD study, the authors autopsied all World Health Organization (WHO)–defined sudden cardiac deaths (SCDs) and found that only 56% had an arrhythmic cause; resuscitated sudden cardiac arrests (SCAs) were excluded because they did not die suddenly. They hypothesized that causes underlying resuscitated SCAs would be similarly heterogeneous.
The Shadows of Sudden Cardiac Death?
Eric C. Stecker, Babak Nazer
doi : 10.1016/j.jacc.2021.03.321
Volume 77, Issue 19, 18 May 2021, Pages 2363-2365
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials
Lawrence A. Leiter, Deepak L. Bhatt, Darren K. McGuire, Hwee Teoh, ... Philippe Gabriel Steg
doi : 10.1016/j.jacc.2021.03.298
Volume 77, Issue 19, 18 May 2021, Pages 2366-2377
THEMIS (The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study) (n = 19,220) and its pre-specified THEMIS-PCI (The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study-Percutaneous Coronary Intervention) (n = 11,154) subanalysis showed, in individuals with type 2 diabetes mellitus (median duration 10.0 years; HbA1c 7.1%) and stable coronary artery disease without prior myocardial infarction (MI) or stroke, that ticagrelor plus aspirin (compared with placebo plus aspirin) produced a favorable net clinical benefit (composite of all-cause mortality, MI, stroke, fatal bleeding, and intracranial bleeding) if the patients had a previous percutaneous coronary intervention.
Benefits of Ticagrelor Plus Aspirin According to Diabetes-Related Factors: A Complex Equation?
Jean-Guillaume Dillinger, Patrick Henry
doi : 10.1016/j.jacc.2021.03.319
Volume 77, Issue 19, 18 May 2021, Pages 2378-2381
Impact of Major Residual Lesions on Outcomes After Surgery for Congenital Heart Disease
Meena Nathan, Jami C. Levine, Maria I. Van Rompay, Linda M. Lambert, ... Jane W. Newburger
doi : 10.1016/j.jacc.2021.03.304
Volume 77, Issue 19, 18 May 2021, Pages 2382-2394
Many factors affect outcomes after congenital cardiac surgery.
One Step Closer to Understanding What Is Good Enough
Joshua J. Blinder, Jennifer C. Romano
doi : 10.1016/j.jacc.2021.03.302
Volume 77, Issue 19, 18 May 2021, Pages 2395-2397
Global Prevalence and Impact of Hostility, Discrimination, and Harassment in the Cardiology Workplace
Garima Sharma, Pamela S. Douglas, Sharonne N. Hayes, Roxana Mehran, ... Laxmi S. Mehta
doi : 10.1016/j.jacc.2021.03.301
Volume 77, Issue 19, 18 May 2021, Pages 2398-2409
Discrimination and emotional and sexual harassment create a hostile work environment (HWE). The global prevalence of HWE in cardiology is unknown, as is its impact.
Hostile Work Environment: A Case of the Emperor’s New Clothes?
Javed Butler, Ileana L. Pi?a
doi : 10.1016/j.jacc.2021.04.002
Volume 77, Issue 19, 18 May 2021, Pages 2410-2412
Vascular Lesion–Specific Drug Delivery Systems: JACC State-of-the-Art Review
David Marlevi, Elazer R. Edelman
doi : 10.1016/j.jacc.2021.03.307
Volume 77, Issue 19, 18 May 2021, Pages 2413-2431
Drug delivery is central to modern cardiovascular care, where drug-eluting stents, bioresorbable scaffolds, and drug-coated balloons all aim to restore perfusion while inhibiting exuberant healing.
Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review
Puja B. Parikh, Deepak L. Bhatt, Varun Bhasin, Stefan D. Anker, ... Javed Butler
doi : 10.1016/j.jacc.2021.03.310
Volume 77, Issue 19, 18 May 2021, Pages 2432-2447
Coronary artery disease (CAD) is highly prevalent in patients with heart failure (HF) and accounts for nearly two-thirds of cases. The use of percutaneous coronary intervention (PCI) in HF patients with CAD has markedly increased and has been suggested to be associated with improved outcomes in numerous observational studies. Randomized data comparing the impact of PCI with that of coronary artery bypass graft (CABG) or contemporary guideline-directed medical therapy alone on clinical outcomes and myocardial recovery in patients with HF are lacking.
Long-Term Complications After Aortic Coarctation Stenting
Maria Alvarez-Fuente, Ana Ayala, Elvira Garrido-Lestache, Ramon Bermudez-Ca?ete, ... Maria Jesus del Cerro
doi : 10.1016/j.jacc.2021.03.303
Volume 77, Issue 19, 18 May 2021, Pages 2448-2450
TAV-in-TAV Versus TAV-in-SAV: A Troublesome Analysis and the Wrong Question
Toby Rogers, Giorgio A. Medranda, Gheorghe Doros, William S. Weintraub, Ron Waksman
doi : 10.1016/j.jacc.2021.03.297
Volume 77, Issue 19, 18 May 2021, Pages 2450-2451
